Wealthfront’s Dynavax Technologies DVAX Stock Holding History

Wealthfront’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4	Closed	–	–	1307
2015 Q1	$0	Buy	+4	New	+$77	﹤0.01%	1209

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wealthfront's DVAX Position: Q2 2015 in Review

Wealthfront sold out of Dynavax Technologies (DVAX) in Q2 2015, closing a stake of 4 shares.

Wealthfront first reported a position in DVAX in Q1 2015 and held it in 1 quarter. The position peaked at $0 in Q1 2015. 120 funds tracked by Wall St. Rank hold DVAX as of Q2 2015.

Wealthfront reported no remaining Dynavax Technologies position as of Q2 2015 after selling out during the quarter.
Wealthfront sold 4 Dynavax Technologies shares in Q2 2015.
Wealthfront first reported a position in Dynavax Technologies in Q1 2015 and held it in 1 quarter.
Wealthfront's Dynavax Technologies position peaked at $0 in Q1 2015.
120 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2015.

Based on Wealthfront's 13F filing for Q2 2015, filed 18 Aug 2015.